Literature DB >> 2219205

Age-related spontaneous intracerebral hematoma in a German community.

H Schütz1, R H Bödeker, M Damian, P Krack, W Dorndorf.   

Abstract

We investigated incidence, age distribution in relation to etiology, and localization of spontaneous intracerebral hematoma in 100 consecutive cases. Incidence in the total population of the Giessen area was estimated to be greater than 11/100,000 inhabitants/yr and increased with age. There was a trend toward higher incidence in males. Overall mortality was 27%, 22% of 58 patients aged less than 70 years and 33% of 42 patients aged greater than or equal to 70 years. Hypertensive putaminal hematoma showed the highest mortality rate (42%, 10 of 24 cases). Chronic alcoholism and anticoagulant medication influenced the mortality rate unfavourably. We found the following localizations and etiologies to have a specific relation with age: 1) lobar hematomas from vascular malformations, group aged less than 40 years; 2) hypertensive putaminal hematomas and hypertensive thalamic hematomas, group aged 40-69 years; and 3) lobar hematomas, group aged greater than or equal to 70 years. Alcoholism was an additional factor in 38% of the 13 middle-aged men with hypertensive putaminal hematomas. Fourteen cases of spontaneous intracerebral hematoma were possibly due to cerebral amyloid angiopathy. Six of these 14 patients had recurrent lobar hematomas, but only three of the six could be histologically investigated. In these three cases, cerebral amyloid angiopathy was proven.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2219205     DOI: 10.1161/01.str.21.10.1412

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  12 in total

1.  Intracerebral Hemorrhage.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-05       Impact factor: 3.598

2.  The relation between different dimensions of alcohol consumption and burden of disease: an overview.

Authors:  Jürgen Rehm; Dolly Baliunas; Guilherme L G Borges; Kathryn Graham; Hyacinth Irving; Tara Kehoe; Charles D Parry; Jayadeep Patra; Svetlana Popova; Vladimir Poznyak; Michael Roerecke; Robin Room; Andriy V Samokhvalov; Benjamin Taylor
Journal:  Addiction       Date:  2010-03-15       Impact factor: 6.526

3.  Primary intracerebral haemorrhage in the Jyväskylä region, central Finland, 1985-89: incidence, case fatality rate, and functional outcome.

Authors:  R Fogelholm; M Nuutila; A L Vuorela
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-07       Impact factor: 10.154

Review 4.  Management of ruptured brain arteriovenous malformations.

Authors:  Brad E Zacharia; Kerry A Vaughan; Adam Jacoby; Zachary L Hickman; Daniel Bodmer; E Sander Connolly
Journal:  Curr Atheroscler Rep       Date:  2012-08       Impact factor: 5.113

5.  Is hypertension a more frequent risk factor for deep than for lobar supratentorial intracerebral haemorrhage?

Authors:  C A Jackson; C L M Sudlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-05-11       Impact factor: 10.154

Review 6.  Pharmacotherapy for the secondary prevention of stroke.

Authors:  Kazunori Toyoda
Journal:  Drugs       Date:  2009       Impact factor: 9.546

7.  Anticoagulation in patients with atrial fibrillation. Don't deny treatment to elderly people.

Authors:  T Solanki
Journal:  BMJ       Date:  1993-12-04

Review 8.  A review of stereotaxy and lysis for intracranial hemorrhage.

Authors:  Uzma Samadani; Veit Rohde
Journal:  Neurosurg Rev       Date:  2008-10-01       Impact factor: 3.042

Review 9.  Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.

Authors:  Eric E Smith; Steven M Greenberg
Journal:  Curr Atheroscler Rep       Date:  2003-07       Impact factor: 5.113

10.  Tissue plasminogen activator induced delayed edema in experimental porcine intracranial hemorrhage: reduction with plasminogen activator inhibitor-1 administration.

Authors:  Naureen Keric; Gerrit Steffen Maier; Uzma Samadani; Kai Kallenberg; Peter Dechent; Wolfgang Brueck; Jan Heuer; Veit Rohde
Journal:  Transl Stroke Res       Date:  2012-05-26       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.